People Focused. Passion Powered. Purpose Driven.

We are dedicated to developing new therapies for Alzheimer’s, Parkinson's, and other neurodegenerative disorders, bringing hope and meaningful change to patients and their families, with compassion guiding our every step.

Phase 3 Alzheimer's Disease Trial

  • Study ID: ANVS-25001
  • CT.gov ID: NCT06709014
  • Start date: 02.2025
  • Status: Enrolled
Learn More

Open-Label Extension Alzheimer's Study

  • Study ID: ANVS-26001
  • CT.gov ID: NCT07757204
  • Start date: 10.2026
  • Status: Accepting patients
Learn More

Open-Label Extension Parkinson's Study

  • Study ID: ANVS-25002
  • CT.gov ID: NCT07284784
  • Start date: 01.2026
  • Status: Accepting patients
Learn More
Expanded Access Policy